Theodora Sideri

Dr. Theodora Sideri

School of Medicine, Laboratory of Biochemistry, University of Thessaly, Larissa, Greece
+1
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ALAdrien Leger
Adrien Leger
PAPaulo P. Amaral
Paulo P. Amaral
LPLuca Pandolfini
Luca Pandolfini
CCCharlotte Capitanchik
Charlotte Capitanchik
FCFederica Capraro
Federica Capraro
TKTony Kouzarides
Tony Kouzarides
RNA molecules undergo a vast array of chemical post-transcriptional modifications (PTMs) that can affect their structure and interaction properties. In recent years, a growing number of PTMs have been successfully mapped to the transcriptome using experimental approaches relying on high-throughput sequencing. Oxford Nanopore direct-RNA sequencing has been shown to be sensitive to RNA modifications. We developed and validated Nanocompore, a robust analytical framework that identifies modifications from these data. Our strategy compares an RNA sample of interest against a non-modified control sample, not requiring a training set and allowing the use of replicates. We show that Nanocompore can detect different RNA modifications with position accuracy in vitro, and we apply it to profile m6A in vivo in yeast and human RNAs, as well as in targeted non-coding RNAs. We confirm our results with orthogonal methods and provide novel insights on the co-occurrence of multiple modified residues on individual RNA molecules.

9 February 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DJDaniel Charlton Jeffares
Daniel Charlton Jeffares
CRCharalampos (Babis) Rallis
Charalampos (Babis) Rallis
ARAdrien Rieux
Adrien Rieux
DSDoug Speed
Doug Speed
MPMartin Převorovský
Martin Převorovský
Jurg BahlerJurg Bahler
Jurg Bahler

1 January 2012 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
TJTherese Jacobson
Therese Jacobson
CNClara Navarrete
Clara Navarrete
SSSandeep Kumar Sharma
Sandeep Kumar Sharma
Theodora SideriTheodora Sideri
Theodora Sideri
SISebastian Ibstedt
Sebastian Ibstedt
MTMarkus Tamas
Markus Tamas
Several metals and metalloids profoundly affect biological systems, but their impact on the proteome and mechanisms of toxicity are not fully understood. Here, we demonstrate that arsenite causes protein aggregation in Saccharomyces cerevisiae. Various molecular chaperones were found to be associated with arsenite-induced aggregates indicating that this metalloid promotes protein misfolding. Using in vivo and in vitro assays, we show that proteins in the process of synthesis/folding are particularly sensitive to arsenite-induced aggregation, that arsenite interferes with protein folding by acting on unfolded polypeptides, and that arsenite directly inhibits chaperone activity. Thus, folding inhibition contributes to arsenite toxicity in two ways: by aggregate formation and by chaperone inhibition. Importantly, arsenite-induced protein aggregates can act as seeds committing other, labile proteins to misfold and aggregate. Our findings describe a novel mechanism of toxicity that may explain the suggested role of this metalloid in the etiology and pathogenesis of protein folding disorders associated with arsenic poisoning.

3 September 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
DDDavid Dierks
David Dierks
MGMiguel Angel Garcia-Campos
Miguel Angel Garcia-Campos
AUAnna Uzonyi
Anna Uzonyi
MSModi Safra
Modi Safra
SESarit Edelheit
Sarit Edelheit
SSSchraga Schwartz
Schraga Schwartz

1 June 2005 in Microbiology
Verified
Journal Article
Open access
ESEdward R. Sumner
Edward R. Sumner
ASAnupama Shanmuganathan
Anupama Shanmuganathan
Theodora SideriTheodora Sideri
Theodora Sideri
SWSylvia A. Willetts
Sylvia A. Willetts
JHJohn E. Houghton
John E. Houghton
SASimon V. Avery
Simon V. Avery
Oxidative damage in microbial cells occurs during exposure to the toxic metal chromium, but it is not certain whether such oxidation accounts for the toxicity of Cr. Here, aSaccharomyces cerevisiae sod1Δ mutant (defective for the Cu,Zn-superoxide dismutase) was found to be hypersensitive to Cr(VI) toxicity under aerobic conditions, but this phenotype was suppressed under anaerobic conditions. Studies with cells expressing a Sod1p variant (Sod1H46C) showed that the superoxide dismutase activity rather than the metal-binding function of Sod1p was required for Cr resistance. To help identify the macromolecular target(s) of Cr-dependent oxidative damage, cells deficient for the reduction of phospholipid hydroperoxides (gpx3Δ andgpx1Δ/gpx2Δ/gpx3Δ) and for the repair of DNA oxidation (ogg1Δ andrad30Δ/ogg1Δ) were tested, but were found not to be Cr-sensitive. In contrast,S. cerevisiae msraΔ (mxr1Δ) andmsrbΔ (ycl033cΔ) mutants defective for peptide methionine sulfoxide reductase (MSR) activity exhibited a Cr sensitivity phenotype, and cells overexpressing these enzymes were Cr-resistant. Overexpression of MSRs also suppressed the Cr sensitivity ofsod1Δ cells. The inference that protein oxidation is a primary mechanism of Cr toxicity was corroborated by an observed ∼20-fold increase in the cellular levels of protein carbonyls within 30 min of Cr exposure. Carbonylation was not distributed evenly among the expressed proteins of the cells; certain glycolytic enzymes and heat-shock proteins were specifically targeted by Cr-dependent oxidative damage. This study establishes an oxidative mode of Cr toxicity inS. cerevisiae, which primarily involves oxidative damage to cellular proteins.

15 September 2012 in Molecular Biology of the Cell
Verified
Journal Article
Open access
AAAlawiah Alhebshi
Alawiah Alhebshi
Theodora SideriTheodora Sideri
Theodora Sideri
SHSara L. Holland
Sara L. Holland
SASimon V. Avery
Simon V. Avery
Oxidative stress mediated by reactive oxygen species (ROS) is linked to degenerative conditions in humans and damage to an array of cellular components. However, it is unclear which molecular target(s) may be the primary “Achilles’ heel” of organisms, accounting for the inhibitory action of ROS. Rli1p (ABCE1) is an essential and highly conserved protein of eukaryotes and archaea that requires notoriously ROS-labile cofactors (Fe-S clusters) for its functions in protein synthesis. In this study, we tested the hypothesis that ROS toxicity is caused by Rli1p dysfunction. In addition to being essential, Rli1p activity (in nuclear ribosomal-subunit export) was shown to be impaired by mild oxidative stress in yeast. Furthermore, prooxidant resistance was decreased by RLI1 repression and increased by RLI1 overexpression. This Rlip1 dependency was abolished during anaerobicity and accentuated in cells expressing a FeS cluster–defective Rli1p construct. The protein's FeS clusters appeared ROS labile during in vitro incubations, but less so in vivo. Instead, it was primarily55FeS-cluster supply to Rli1p that was defective in prooxidant-exposed cells. The data indicate that, owing to its essential nature but dependency on ROS-labile FeS clusters, Rli1p function is a primary target of ROS action. Such insight could help inform new approaches for combating oxidative stress–related disease.